From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease.
暂无分享，去创建一个
I. Carvalho | E. Sakamoto-Hojo | Carlos Roca | C. Requena | V. Sebastián-Pérez | C. Pérez | Ana Martínez | N. Campillo | T. Chierrito | Susimaire Pedersoli-Mantoani | W. O. Castillo | N. C. Moreira | C. Takahashi | J. Jiménez-Barbero | F. Cañada | F. Cañada | J. Jiménez‐Barbero | C. Requeña